136 related articles for article (PubMed ID: 11434709)
1. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
[TBL] [Abstract][Full Text] [Related]
2. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
Rigla M; Mateo J; Fontcuberta J; Souto JC; de Leiva A; Pérez A
Thromb Haemost; 2000 Aug; 84(2):223-7. PubMed ID: 10959693
[TBL] [Abstract][Full Text] [Related]
3. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
4. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
8. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
10. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
Thorand B; Baumert J; Döring A; Schneider A; Chambless L; Löwel H; Kolb H; Koenig W
Thromb Haemost; 2006 Jan; 95(1):134-41. PubMed ID: 16543972
[TBL] [Abstract][Full Text] [Related]
11. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
Sakkinen PA; Cushman M; Psaty BM; Kuller LH; Bajaj SP; Sabharwal AK; Boineau R; Macy E; Tracy RP
Thromb Haemost; 1998 Jul; 80(1):134-9. PubMed ID: 9684799
[TBL] [Abstract][Full Text] [Related]
12. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
Agledahl I; Brodin E; Svartberg J; Hansen JB
Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
[TBL] [Abstract][Full Text] [Related]
13. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
Małyszko J; Małyszko JS; Myśliwiec M
Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
15. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
16. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease.
Cheng G; Shan J; Xu G; Liu P; Zhou Y; Zhu Y; Lu X
J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881
[TBL] [Abstract][Full Text] [Related]
17. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
18. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
